Antiviral Drugs Market Growth Analysis and Forecast by 2035

by Robertclarke

The Antiviral Drugs Market is estimated to grow at a CAGR of 6.3% during the period 2022-2035, claims Roots Analysis

Over the years, there has been a growing focus on the development of safe and effective novel antiviral therapeutics owing to the rising cases of life-threatening viral diseases

Roots Analysis is pleased to announce the publication of its recent study, titled, “Antiviral Drugs Market, 2022 – 2035”

To get a sample copy of the latest market report, visit

The study features an in-depth analysis, highlighting the capabilities of antiviral drug developers engaged in this domain. Amongst other elements, the report features:
 A detailed assessment of the current market landscape of commercially available antiviral drugs.
 A detailed assessment of the current market landscape of clinical-stage antiviral drugs.
 An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2019-2022 (till May).
 A detailed analysis of investments that have been made into companies engaged in the antiviral drugs domain, during the period 2019-2022 (till May).
 A qualitative analysis of the five competitive forces under an insightful Porter’s Five Forces framework.
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in development of antiviral drugs.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
 Mechanism of Action
 Fusion Inhibitors
 DNA Polymerases
 Protease Inhibitors
 Reverse Transcriptase Inhibitors
 Other Mechanisms

Target Indication
 Human Immunodeficiency Virus Infection
 Hepatitis
 Herpes Simplex Virus Infection
 Cytomegalovirus Infection
 Influenza
 Coronavirus Infection
 Other Target Indications

Type of Drug Target
 Virus Targets
 Host Targets

Type of Therapy
 Monotherapy
 Combination Therapy

Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Rest of the World

Key companies covered in the report
 AbbVie
 AstraZeneca
 Bristol-Myers Squibb
 Genentech
 Gilead Sciences
 GlaxoSmithKline (GSK)
 Johnson & Johnson
 Merck
 Novartis
 Pfizer
 Roche
 ViiV Healthcare

For additional details, please visit

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Ben Johnson
+1 (415) 800 3415

You may also like

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
Update Required Flash plugin